Zobrazeno 1 - 10 of 361 pro vyhledávání: '"Lecoq I"'
1
Akademický článek
The antitumor activity of TGFβ-specific T cells is dependent on IL-6 signaling.
Autor: Perez-Penco M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Byrdal M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Lara de la Torre L; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Ballester M; Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Khan S; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Siersbæk M; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Lecoq I; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; IO Biotech ApS, Copenhagen, Denmark., Madsen CO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Kjeldsen JW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Hansen M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Johansen JS; Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Olsen LR; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Grøntved L; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Chen IM; Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Arnes L; Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Holmström MO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. Mads.Hald.Andersen@regionh.dk.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. Mads.Hald.Andersen@regionh.dk.
Publikováno v: Cellular & molecular immunology [Cell Mol Immunol] 2025 Jan; Vol. 22 (1), pp. 111-126. Date of Electronic Publication: 2024 Dec 09.
Zobrazit plný text záznamu
2
Akademický článek
TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts.
Autor: Perez-Penco M; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT- DK), Herlev, Denmark., Lara de la Torre L; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT- DK), Herlev, Denmark., Lecoq I; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT- DK), Herlev, Denmark., Martinenaite E; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT- DK), Herlev, Denmark., Andersen MH; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT- DK), Herlev, Denmark Mads.Hald.Andersen@regionh.dk.; Department of Immunology, University of Copenhagen, Kobenhavn, Denmark.
Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Feb 27; Vol. 12 (2). Date of Electronic Publication: 2024 Feb 27.
Zobrazit plný text záznamu
3
Akademický článek
TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer.
Autor: Perez-Penco M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Weis-Banke SE; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Schina A; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Siersbæk M; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Hübbe ML; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Jørgensen MA; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Lecoq I; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; IO Biotech ApS, Copenhagen, Denmark., Lara de la Torre L; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Bendtsen SK; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Martinenaite E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; IO Biotech ApS, Copenhagen, Denmark., Holmström MO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Madsen DH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Ødum N; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Grøntved L; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark Mads.Hald.Andersen@regionh.dk.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Dec; Vol. 10 (12).
Zobrazit plný text záznamu
4
Akademický článek
CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment.
Autor: Lecoq I; Department of Research and Development, IO Biotech ApS, Copenhagen, Denmark.; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Kopp KL; Department of Research and Development, IO Biotech ApS, Copenhagen, Denmark., Chapellier M; Department of Research and Development, IO Biotech ApS, Copenhagen, Denmark., Mantas P; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Martinenaite E; Department of Research and Development, IO Biotech ApS, Copenhagen, Denmark.; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Perez-Penco M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Rønn Olsen L; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Zocca MB; Department of Research and Development, IO Biotech ApS, Copenhagen, Denmark., Wakatsuki Pedersen A; Department of Research and Development, IO Biotech ApS, Copenhagen, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Publikováno v: Oncoimmunology [Oncoimmunology] 2022 Aug 29; Vol. 11 (1), pp. 2115655. Date of Electronic Publication: 2022 Aug 29 (Print Publication: 2022).
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Mucoviscidose: dépistage et prise en charge
Autor: Brouard, J., Lecoq, I., Vérine, C., Laurans, M., Travert, Duhamel, J.F.
Publikováno v: In Journal de pediatrie et de puericulture 2000 13(8):458-465
Zobrazit plný text záznamu
8
Akademický článek
Peptide vaccination directed against IDO1-expressing immune cells elicits CD8 + and CD4 + T-cell-mediated antitumor immunity and enhanced anti-PD1 responses.
Autor: Dey S; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA., Sutanto-Ward E; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA., Kopp KL; IO Biotech ApS, Copenhagen, Denmark., DuHadaway J; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA., Mondal A; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA., Ghaban D; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA.; Drexel University College of Medicine, Philadelphia, Pennsylvania, USA., Lecoq I; IO Biotech ApS, Copenhagen, Denmark., Zocca MB; IO Biotech ApS, Copenhagen, Denmark., Merlo LMF; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA., Mandik-Nayak L; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA., Andersen MH; IO Biotech ApS, Copenhagen, Denmark.; National Center for Cancer Immune Therapy, University of Copenhagen, Copenhagen, Denmark., Pedersen AW; IO Biotech ApS, Copenhagen, Denmark., Muller AJ; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA muller@limr.org.
Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Jul; Vol. 8 (2).
Zobrazit plný text záznamu
9
Akademický článek
Cancer Vaccines: Recent Insights and Future Directions.
Autor: Malacopol, Aretia-Teodora1 (AUTHOR) tmalacopol@hervolutiontx.com, Holst, Peter Johannes1,2 (AUTHOR) pholst@hervolutiontx.com
Publikováno v: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11256. 16p.
Zobrazit plný text záznamu
10
Akademický článek
TGFB2 mRNA Levels Prognostically Interact with Interferon-Alpha Receptor Activation of IRF9 and IFI27, and an Immune Checkpoint LGALS9 to Impact Overall Survival in Pancreatic Ductal Adenocarcinoma.
Autor: Qazi, Sanjive1 (AUTHOR) sanjive.qazi@autotelicinc.com, Trieu, Vuong1 (AUTHOR)
Publikováno v: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11221. 27p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje